Annual ROE
-66.82%
-12.23%-22.40%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual return on equity is -66.82%, with the most recent change of -12.23% (-22.40%) on December 31, 2023.
- During the last 3 years, ZNTL annual ROE has fallen by -28.63% (-74.97%).
- ZNTL annual ROE is now -217.23% below its all-time high of 57.00%, reached on December 31, 2019.
Performance
ZNTL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-43.92%
+0.31%+0.70%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly return on equity is -43.92%, with the most recent change of +0.31% (+0.70%) on September 30, 2024.
- Over the past year, ZNTL quarterly ROE has increased by +18.85% (+30.03%).
- ZNTL quarterly ROE is now -172.32% below its all-time high of 60.73%, reached on March 31, 2020.
Performance
ZNTL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ZNTL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.4% | +30.0% |
| 3 y3 years | -75.0% | +30.0% |
| 5 y5 years | +21.4% | +30.0% |
ZNTL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.2% | at low | at high | +31.8% |
| 5 y | 5-year | -217.2% | at low | -172.3% | +92.2% |
| alltime | all time | -217.2% | +21.4% | -172.3% | +92.2% |
Zentalis Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -43.92%(-0.7%) |
| Jun 2024 | - | -44.23%(-4.0%) |
| Mar 2024 | - | -46.06%(-28.0%) |
| Dec 2023 | -66.82%(+22.4%) | -63.95%(+1.9%) |
| Sep 2023 | - | -62.77%(-2.5%) |
| Jun 2023 | - | -64.40%(+14.9%) |
| Mar 2023 | - | -56.03%(-2.4%) |
| Dec 2022 | -54.59% | -57.40%(-2.2%) |
| Sep 2022 | - | -58.70%(+24.8%) |
| Jun 2022 | - | -47.03%(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -51.80%(+1.9%) |
| Dec 2021 | -43.61%(+14.2%) | -50.81%(+1.8%) |
| Sep 2021 | - | -49.90%(-20.6%) |
| Jun 2021 | - | -62.82%(+17.2%) |
| Mar 2021 | - | -53.61%(-12.8%) |
| Dec 2020 | -38.19%(-167.0%) | -61.46%(-36.9%) |
| Sep 2020 | - | -97.33%(-82.7%) |
| Jun 2020 | - | -562.94%(-1027.0%) |
| Mar 2020 | - | 60.73%(+6.5%) |
| Dec 2019 | 57.00%(-167.0%) | 57.00% |
| Dec 2018 | -85.05% | - |
FAQ
- What is Zentalis Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual ROE year-on-year change?
- What is Zentalis Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly ROE year-on-year change?
What is Zentalis Pharmaceuticals annual return on equity?
The current annual ROE of ZNTL is -66.82%
What is the all time high annual ROE for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual return on equity is 57.00%
What is Zentalis Pharmaceuticals annual ROE year-on-year change?
Over the past year, ZNTL annual return on equity has changed by -12.23% (-22.40%)
What is Zentalis Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ZNTL is -43.92%
What is the all time high quarterly ROE for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly return on equity is 60.73%
What is Zentalis Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ZNTL quarterly return on equity has changed by +18.85% (+30.03%)